Increased Time in Range with Ultra Rapid Lispro Treatment in Participants with Type 2 Diabetes: PRONTO-Time in Range.

Timothy S BaileyBruce W BodeQianqian WangAlastair W KnightsAnnette M Chang

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2023)

In people with T2D, URLi in an MDI regimen was efficacious with improved glycemic control including TIR, HbA1c, and postprandial glucose without increased hypoglycemia/TBR. CLINICAL TRIAL REGISTRATION NUMBER: NCT04605991.

Keyphrases

glycemic control
blood glucose
type diabetes
clinical trial
weight loss
insulin resistance
high resolution
study protocol
phase ii
double blind
metabolic syndrome
skeletal muscle
quantum dots
replacement therapy
loop mediated isothermal amplification